# FDA Inspection 1040189 - Medix Biochemica USA, Inc. - December 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/medix-biochemica-usa-inc/33a15ece-04e5-498e-a141-2558bd90c5d1
Source feed: FDA_Inspections

> FDA Inspection 1040189 for Medix Biochemica USA, Inc. on December 19, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1040189
- Company Name: Medix Biochemica USA, Inc.
- Inspection Date: 2017-12-19
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1205335 - 2023-05-03](https://www.keypedia.com/records/fda_inspections/medix-biochemica-usa-inc/bbd676bd-11bd-4b47-9aac-b19e8ffa6fbd)
- [FDA Inspection 797510 - 2012-09-05](https://www.keypedia.com/records/fda_inspections/medix-biochemica-usa-inc/97ea635b-b97d-409c-94c1-f827443c7f46)
- [FDA Inspection 797510 - 2012-09-05](https://www.keypedia.com/records/fda_inspections/medix-biochemica-usa-inc/d81b914f-7e3b-484d-bc8d-6e19c361a713)

Company: https://www.keypedia.com/companies/medix-biochemica-usa-inc/15e1a021-09a1-4a06-bae7-8a1d49041cc7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d